Literature DB >> 26455958

Aging and age related stresses: a senescence mechanism of intervertebral disc degeneration.

F Wang1, F Cai2, R Shi3, X-H Wang4, X-T Wu5.   

Abstract

Intervertebral disc (IVD) degeneration is a complicated process that involves both age-related change and tissue damage caused by multiple stresses. In a degenerative IVD, cellular senescence accumulates and is associated with reduced proliferation, compromised self-repair, increased inflammatory response, and enhanced catabolic metabolism. In this review, we decipher the senescence mechanism of IVD degeneration (IVDD) by interpreting how aging coordinates with age-related, microenvironment-derived stresses in promoting disc cell senescence and accelerating IVDD. After chronic and prolonged replication, cell senescence may occur as a natural part of the disc aging process, but can potentially be accelerated by growth factor deficiency, oxidative accumulation, and inflammatory irritation. While acute disc injury, excessive mechanical overloading, diabetes, and chronic tobacco smoking contribute to the amplification of senescence-inducing stresses, the avascular nature of IVD impairs the immune-clearance of the senescent disc cells, which accumulate in cell clusters, demonstrate inflammatory and catabolic phenotypes, deteriorate disc microenvironment, and accelerate IVDD. Anti-senescence strategies, including telomerase transduction, supply of growth factors, and blocking cell cycle inhibitors, have been shown to be feasible in rescuing disc cells from early senescence, but their efficiency for disc regeneration requires more in vivo validations. Guidelines dedicated to avoiding or alleviating senescence-inducing stresses might decelerate cellular senescence and benefit patients with IVD degenerative diseases.
Copyright © 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aging; Cellular senescence; Intervertebral disc; Microenvironment

Mesh:

Year:  2015        PMID: 26455958     DOI: 10.1016/j.joca.2015.09.019

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  118 in total

1.  A Membranome-Centered Approach Defines Novel Biomarkers for Cellular Subtypes in the Intervertebral Disc.

Authors:  Guus G H van den Akker; Lars M T Eijssen; Stephen M Richardson; Lodewijk W van Rhijn; Judith A Hoyland; Tim J M Welting; Jan Willem Voncken
Journal:  Cartilage       Date:  2018-04-09       Impact factor: 4.634

2.  TRPC6 in simulated microgravity of intervertebral disc cells.

Authors:  Alfredo Franco-Obregón; Elena Cambria; Helen Greutert; Timon Wernas; Wolfgang Hitzl; Marcel Egli; Miho Sekiguchi; Norbert Boos; Oliver Hausmann; Stephen J Ferguson; Hiroshi Kobayashi; Karin Wuertz-Kozak
Journal:  Eur Spine J       Date:  2018-07-02       Impact factor: 3.134

3.  A histocytological and radiological overview of the natural history of intervertebral disk: from embryonic formation to age-related degeneration.

Authors:  Feng Wang; Cong Zhang; Arjun Sinkemani; Rui Shi; Zhi-Yang Xie; Lu Chen; Lu Mao; Xiao-Tao Wu
Journal:  Eur Spine J       Date:  2019-02-04       Impact factor: 3.134

4.  Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud's phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway.

Authors:  Chieh-Yu Shen; Ko-Jen Li; Pei-Hsuan Lai; Chia-Li Yu; Song-Chou Hsieh
Journal:  Clin Rheumatol       Date:  2017-09-23       Impact factor: 2.980

Review 5.  Diabetes mellitus as a risk factor for intervertebral disc degeneration: a critical review.

Authors:  Kalliopi Alpantaki; Alkisti Kampouroglou; Christos Koutserimpas; Grigoris Effraimidis; Alexander Hadjipavlou
Journal:  Eur Spine J       Date:  2019-06-14       Impact factor: 3.134

6.  Senotherapeutic drugs for human intervertebral disc degeneration and low back pain.

Authors:  Hosni Cherif; Daniel G Bisson; Matthew Mannarino; Oded Rabau; Jean A Ouellet; Lisbet Haglund
Journal:  Elife       Date:  2020-08-21       Impact factor: 8.140

7.  Moxibustion alleviates intervertebral disc degeneration via activation of the HIF-1α/VEGF pathway in a rat model.

Authors:  Bo Zhang; Qian Zhao; Yushi Li; Jinxue Zhang
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

8.  Intervertebral Disc Aging, Degeneration, and Associated Potential Molecular Mechanisms.

Authors:  Qiuqian Wu; Jason H Huang
Journal:  J Head Neck Spine Surg       Date:  2017-11-16

9.  MicroRNA-194 Inhibits Lipopolysaccharide-Induced Inflammatory Response in Nucleus Pulposus Cells of the Intervertebral Disc by Targeting TNF Receptor-Associated Factor 6 (TRAF6).

Authors:  Lili Kong; Mingxiao Sun; Zhaofu Jiang; Liming Li; Bing Lu
Journal:  Med Sci Monit       Date:  2018-05-10

Review 10.  [Research progress of hydrogel used for regeneration of nucleus pulposus in intervertebral disc degeneration].

Authors:  Kun Shi; Yong Huang; Leizhen Huang; Jingcheng Wang; Yuhan Wang; Ganjun Feng; Limin Liu; Yueming Song
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.